AKT1 and neoplasm: For the mechanism by which LOX promotes tumor progression, Erler et al. found that the HRE in the LOX promoter is a downstream target of hypoxia-inducible factor 1 (HIF-1) [17]; meanwhile, LOX can also upregulate HIF-1α protein expression by activating the PI3K/Akt pathway.